These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11768609)

  • 21. Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma.
    Hirasawa Y; Arai M; Imazeki F; Tada M; Mikata R; Fukai K; Miyazaki M; Ochiai T; Saisho H; Yokosuka O
    Oncology; 2006; 71(1-2):77-85. PubMed ID: 17341888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DNA demethylating agent 5-aza-2'-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells.
    Almstedt M; Blagitko-Dorfs N; Duque-Afonso J; Karbach J; Pfeifer D; Jäger E; Lübbert M
    Leuk Res; 2010 Jul; 34(7):899-905. PubMed ID: 20381863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation-dependent regulation of TrkA, TrkB, and TrkC genes in human hepatocellular carcinoma.
    Jin W; Lee JJ; Kim MS; Son BH; Cho YK; Kim HP
    Biochem Biophys Res Commun; 2011 Mar; 406(1):89-95. PubMed ID: 21295543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
    Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
    Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
    Venkataraman GM; Yatin M; Marcinek R; Ain KB
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma.
    Li J; Yang Y; Fujie T; Baba K; Ueo H; Mori M; Akiyoshi T
    Clin Cancer Res; 1996 Sep; 2(9):1619-25. PubMed ID: 9816341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma].
    Zhang CJ; Li HM; Yau LM; Suen KW; Zhou GY; Yu F; Liew CT
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):433-6. PubMed ID: 15498213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma.
    Lal G; Padmanabha L; Smith BJ; Nicholson RM; Howe JR; O'Dorisio MS; Domann FE
    Cancer; 2006 Dec; 107(12):2752-9. PubMed ID: 17103461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
    Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
    Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
    Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis.
    Kanai Y; Hui AM; Sun L; Ushijima S; Sakamoto M; Tsuda H; Hirohashi S
    Hepatology; 1999 Mar; 29(3):703-9. PubMed ID: 10051471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI; Lee HS; Kim SH; Kim WH
    Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.
    Nicoll G; Crichton DN; McDowell HE; Kernohan N; Hupp TR; Thompson AM
    Br J Cancer; 2001 Dec; 85(12):1878-82. PubMed ID: 11747329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trop2 is a potential biomarker for the promotion of EMT in human breast cancer.
    Zhao W; Kuai X; Zhou X; Jia L; Wang J; Yang X; Tian Z; Wang X; Lv Q; Wang B; Zhao Y; Huang W
    Oncol Rep; 2018 Aug; 40(2):759-766. PubMed ID: 29901160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines.
    Nixdorf S; Grimm MO; Loberg R; Marreiros A; Russell PJ; Pienta KJ; Jackson P
    Cancer Lett; 2004 Nov; 215(2):209-20. PubMed ID: 15488640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
    Ogawa K; Utsunomiya T; Mimori K; Yamashita K; Okamoto M; Tanaka F; Inoue H; Ikeda Y; Saku M; Murayama S; Mori M
    Int J Oncol; 2005 Aug; 27(2):417-26. PubMed ID: 16010423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.